Foti D, Rapoport B
Thyroid Molecular Biology Unit, Veterans' Administration Medical Center, San Francisco, California 94121.
Endocrinology. 1990 Jun;126(6):2983-8. doi: 10.1210/endo-126-6-2983.
We studied the oligosaccharide moieties of recombinant human thyroid peroxidase (hTPO) expressed in Chinese hamster ovary (CHO) cells, and the role of these glycans in hTPO antigenicity in Hashimoto's thyroiditis. To determine whether hTPO carbohydrate moieties were N-linked, O-linked, or both, and to obtain information about the characteristics of the carbohydrate component(s), we digested hTPO with deglycosylating enzymes of varying specificity. Proteins in CHO-TPO cells were labeled with [35S]methionine, and hTPO was immunoprecipitated with anti-hTPO antibodies present in Hashimoto's thyroiditis serum. Digestion with endoglycosidase (endo) F, which removes both complex and polymannose N-linked glycans, increased the electrophoretic mobility of the hTPO doublet from approximately 115 kD and 110 kD to 110 kD and 105 kD. Endo H, which acts similarly to endo F, but only on polymannose, and not complex, glycans, had a similar effect. In contrast, O-glycanase and neuraminidase, which remove O-linked glycans and terminal neuraminic acid, respectively, did not alter the mobility of radiolabeled hTPO. Radiolabeled recombinant hTPO was retained by concanavalin A, but not by wheat germ agglutinin, Ricinus communis agglutinin 1, peanut agglutinin and Ulex europaeus lectins. To determine whether or not the glycan moieties in hTPO play a role in the disease-associated epitopes in Hashimoto's thyroiditis, radiolabeled recombinant hTPO was immunoprecipitated after digestion with N-glycanase. Removal of the N-linked carbohydrate chains with endo F and endo H did not prevent antibody binding. In summary, the present data indicate that: i) hTPO expressed in CHO cells contains N-linked, but not O-linked glycan moieties; ii) the N-linked carbohydrate is primarily of the polymannose variety; and, iii) the glycan moieties do not contribute to the hTPO epitopes in Hashimoto's thyroiditis.
我们研究了在中国仓鼠卵巢(CHO)细胞中表达的重组人甲状腺过氧化物酶(hTPO)的寡糖部分,以及这些聚糖在桥本甲状腺炎中hTPO抗原性方面的作用。为了确定hTPO的碳水化合物部分是N-连接型、O-连接型还是两者皆有,并获取有关碳水化合物成分特征的信息,我们用具有不同特异性的去糖基化酶消化hTPO。CHO-TPO细胞中的蛋白质用[35S]甲硫氨酸标记,hTPO用桥本甲状腺炎血清中的抗hTPO抗体进行免疫沉淀。用内切糖苷酶(endo)F消化,该酶可去除复杂型和多聚甘露糖型N-连接聚糖,使hTPO双峰的电泳迁移率从约115 kD和110 kD增加到110 kD和105 kD。内切糖苷酶H的作用与内切糖苷酶F相似,但仅作用于多聚甘露糖型聚糖,而非复杂型聚糖,也有类似效果。相比之下,分别去除O-连接聚糖和末端唾液酸的O-糖苷酶和神经氨酸酶,并未改变放射性标记的hTPO的迁移率。放射性标记的重组hTPO可被伴刀豆球蛋白A保留,但不能被麦胚凝集素、蓖麻凝集素1、花生凝集素和荆豆凝集素保留。为了确定hTPO中的聚糖部分是否在桥本甲状腺炎中与疾病相关的表位中起作用,用N-糖苷酶消化后对放射性标记的重组hTPO进行免疫沉淀。用内切糖苷酶F和内切糖苷酶H去除N-连接的碳水化合物链并不能阻止抗体结合。总之,目前的数据表明:i)在CHO细胞中表达的hTPO含有N-连接型聚糖部分,但不含有O-连接型聚糖部分;ii)N-连接的碳水化合物主要是多聚甘露糖型;iii)聚糖部分对桥本甲状腺炎中hTPO的表位没有贡献。